You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ICP - infected cell protein

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Jakarta (AV-COVID-19)

Completed
  • COVID-19
  • AV-COVID-19
  • Jakarta, Indonesia
    RSPAD Gatot Soebroto
Aug 16, 2021

Bile Acids Metabolism and Genetic Mutation Profile in ICP in

Recruiting
  • Intrahepatic Cholestasis of Pregnancy
  • +2 more
    • Chandigarh, India
      Dr. Madhumita Premkumar
    Jan 17, 2023

    Melanoma Patients Treated With IMLYGIC® to Characterize Risk of

    Recruiting
    • Melanoma
    • Herpetic Infection
      • Jefferson City, Missouri
      • +16 more
      Apr 11, 2022

      TBI (Traumatic Brain Injury) Trial (Ultrasonograghic optic nerve sheath diameter US-ONSD, midazolam, dexmedetomidine)

      Not yet recruiting
      • TBI (Traumatic Brain Injury)
      • Ultrasonograghic optic nerve sheath diameter US-ONSD
      • +3 more
      • (no location specified)
      Apr 21, 2022

      HIV Trial in Montpellier (20 ml blood test)

      Not yet recruiting
      • HIV Infections
      • 20 ml blood test
      • Montpellier, Herault, France
        La Colombiere Hospital
      Feb 8, 2022

      Blood and Reproductive Fluids in HIV-Infected and

      Recruiting
      • HIV
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Role of HIV-1 Tat Protein and Anti-Tat Immune Response In HIV

        Recruiting
        • HIV/AIDS
        • No intervention
        • Rome, Italy
          Infectious Dermatology STI Unit San Gallicano Dermatologic Insti
        Mar 23, 2022

        Healthy Volunteers Trial in Daytona Beach (iCP-NI, Placebo)

        Recruiting
        • Healthy Volunteers
        • Daytona Beach, Florida
          Labcorp Clinical Research Unit Inc.
        Feb 21, 2023

        SARS-CoV-2 Infection in Hematologic Tumors

        Active, not recruiting
        • SARS-CoV-2 Infection
        • Hematologic Malignancy
        • None intervention
        • Beijing, Beijing, China
          Peking University First Hospital
        Jan 13, 2023

        COVID-19 Trial in South Africa (Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer))

        Recruiting
        • COVID-19
        • Ad26.COV2.S (VAC31518, JNJ-78436735) Vaccine, SARS-CoV-2 rS (CovovaxTM), BNT162b2 (Pfizer)
        • Pretoria, Gauteng, South Africa
        • +4 more
        Aug 23, 2022

        ICP Threshold After Decompressive Craniectomy

        Not yet recruiting
        • Traumatic Brain Injury
          • (no location specified)
          Oct 9, 2023

          Double Vaccinated for COVID-19 (For Phase 1 of the Study), Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory

          Recruiting
          • Double Vaccinated for COVID-19 (For Phase 1 of the Study)
          • Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
          • COVAC-2
          • Saline Placebo
          • Burlington, Ontario, Canada
          • +2 more
          Aug 24, 2022

          Hematological Malignancies Trial in Tianjin (ICP-248)

          Not yet recruiting
          • Hematological Malignancies
          • Tianjin, Tianjin, China
            Hematology Hospital, Chinese Academy of Medical Sciences
          Feb 13, 2023

          HIV Trial (Lipovirtide 10mg, Lipovirtide 40mg, Lipovirtide 60mg)

          Not yet recruiting
          • HIV
          • Lipovirtide 10mg
          • +3 more
          • (no location specified)
          Sep 23, 2023

          Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)

          Recruiting
          • Cervical Carcinoma
          • TC-E202 cells
          • +3 more
          • Chongqing, Chongqing, China
            Xiaochun Cheng
          Oct 20, 2022

          Influenza Vaccination Trial in Singapore (Flublok Quadrivalent vaccine, Fluarix Quadrivalent vaccine, Flucelvax Quadrivalent

          Not yet recruiting
          • Influenza Vaccination
          • Flublok Quadrivalent vaccine
          • +2 more
          • Singapore, Singapore
            National Centre for Infectious Diseases (NCID)
          Jul 26, 2022

          Traumatic Brain Injury, Traumatic Encephalopathy Trial (Ketamine Hydrochloride)

          Not yet recruiting
          • Traumatic Brain Injury
          • Traumatic Encephalopathy
          • Ketamine Hydrochloride
          • (no location specified)
          Sep 25, 2023

          HIV-1-infection, Methamphetamine-dependence Trial in San Francisco (Oral Methamphetamine, Placebo oral capsule)

          Recruiting
          • HIV-1-infection
          • Methamphetamine-dependence
          • Oral Methamphetamine
          • Placebo oral capsule
          • San Francisco, California
            San Francisco General Hospital
          Mar 22, 2022

          COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))

          Recruiting
          • COVID-19
          • Recombinant new coronavirus vaccine (CHO cell)
          • Changsha, Hunan, China
            Hunan Provincial Center for Disease Control and Prevention
          Jun 2, 2023

          Mantle Cell Lymphoma Trial in China (ICP-022)

          Active, not recruiting
          • Mantle Cell Lymphoma
          • Hefei, Anhui, China
          • +30 more
          Jul 5, 2022

          Idiopathic Intracranial Hypertension Trial in Montpellier (Blood punction, Central blood sampling, Intracranial pressure

          Not yet recruiting
          • Idiopathic Intracranial Hypertension
          • Blood punction
          • +2 more
          • Montpellier, France
            University Hospital of Montpellier - Gui de Chauliac
          Oct 2, 2023

          Pumilio1 Expression, Sickle Cell Anemia, ß-thalassemia

          Not yet recruiting
          • Sickle Cell Disease, Beta Thalassemia Intermedia
          • RNA Binding Protein Pumilio1 (PUM1) Expression by reverse transcriptase quantatative PCR
          • (no location specified)
          May 30, 2023

          HIV-1-infection Trial in London (ConM SOSIP, EDC ConM SOSIP, ConS UFO)

          Active, not recruiting
          • HIV-1-infection
          • ConM SOSIP
          • +4 more
          • London, United Kingdom
            NIHR Imperial Clinical Resarch Facility
          Jul 25, 2022

          Trauma, Brain, Subarachnoid Hemorrhage, Intracranial Hypertension Trial in Tuebingen (Sonographic determination of the optic

          Not yet recruiting
          • Trauma, Brain
          • +2 more
          • Sonographic determination of the optic nerve sheath diameter
          • Tuebingen, Baden-Wuerttemberg, Germany
            University Hospital Tuebingen
          Apr 17, 2023

          AIDS Trial (Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG))

          Not yet recruiting
          • Acquired Immunodeficiency Syndrome
          • Dolutegravir 50 MG plus lamivudine 300 MG； Dolutegravir/lamivudine (50 MG/300 MG)
          • (no location specified)
          Aug 6, 2022